MEDP

$457.94+4.30 (+0.95%)

Market OpenAs of Mar 17, 7:05 PM UTC

Medpace Holdings, Inc.

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$457.94
Potential Upside
7%
Whystock Fair Value$490.00
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryDiagnostics & Research

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development proc...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.00B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
29.95
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.46
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
70.23%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.69

Recent News

Investor's Business Daily
Mar 16, 2026

Illumina Stock Sees RS Rating Jump To 82

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Illumina stock cleared that benchmark Monday, with a jump from 77 to 82 Monday.   Hone Your Stock-Picking Skills By Focusing On These Factors This unique rating measures market leadership by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 15, 2026

Is Medpace Holdings (MEDP) Still Attractive After Mixed Share Price Performance This Year

If you are wondering whether Medpace Holdings is still fairly priced after its recent run, this article will walk through what the numbers are really saying about its current value. The stock closed at US$450.41, with returns of 5.2% over the last 30 days, a 21.1% decline year to date and a 38.6% gain over the past year, which gives a mixed picture of momentum and changing risk perceptions. Recent news around contract research organizations and clinical development outsourcing has kept...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 9, 2026

Medpace (MEDP) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Medpace (MEDP) closed at $478.54, marking a +1.69% move from the previous day.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 9, 2026

2 Healthcare Stocks with Exciting Potential and 1 We Avoid

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 5.7%, nearly mirrorring the S&P 500.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 6, 2026

3 Profitable Stocks for Long-Term Investors

Companies with solid operating margins have a competitive edge, allowing them to reinvest for sustainable expansion. The best of these businesses balance profitability with reinvestment, setting themselves up for long-term success.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.